搜索临床试验以:医管局BPX V3.3
总计1542个结果
-
National Cancer Centre, SingaporeSingapore General Hospital; Singhealth Duke-NUS Oncology Academic Clinical Programme (ONCO ACP)主动,不招人
-
University Hospitals, LeicesterJafron Biomedical Company Limited尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...完全的
-
Bellicum Pharmaceuticals主动,不招人
-
University of Zurich主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Washington University School of Medicine; University of Texas...主动,不招人
-
River Pharma S.r.l.Opera CRO, a TIGERMED Group Company完全的
-
Majmaah UniversityShiekh Abdullah Al-Twejeri Research Chair for Stroke完全的
-
Invibio LtdMedical Metrics Diagnostics, Inc完全的
-
Advagene Biopharma Co. Ltd.National Taiwan University Hospital完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum Pharmaceuticals撤销复发性急性髓性白血病 | 复发性慢性粒单核细胞白血病 | 复发性骨髓增生异常综合征 | 复发性急性淋巴细胞白血病 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 骨髓增殖性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤 | 骨髓增生异常/骨髓增生性肿瘤,无法分类 | 急性双系白血病 | 复发性急性双表型白血病 | 复发性慢性淋巴细胞白血病 | 复发性母细胞性浆细胞样树突状细胞肿瘤美国
-
University of California, San FranciscoNational Cancer Institute (NCI); National Institutes of Health (NIH)尚未招聘
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)完全的